Previously in Part 1: Endocrine aspects, cardiovascular risk, and sexual functioning. Previously in Part 2: Desistance, persistence, and “objective tests”…

Previously in Part 1: Endocrine aspects, cardiovascular risk, and sexual functioning. No “objective tests”? Affirming treatment and persistent gender dysphoria…

This March, the Journal of Clinical Endocrinology & Metabolism published a letter to the editor from an active voice in…

James Caspian: who is this character? A couple weeks ago, an article came across my feed from the UK’s Sunday…

Over the past few years, I’ve made a regular habit of seeking out and compiling nearly any published research that’s…

Lisa Littman’s now-notorious study on an alleged new “rapid onset gender dysphoria” condition occurring in adolescents as a result of…

Background and description of the issue GnRH analogue medications such as Lupron, Decapeptyl, and Supprelin LA have been in use…

Medical transition by trans people, its prevalence and demographics, and rates of regret of treatment are perennial subjects of public…

Previously: Depersonalization in gender dysphoria: widespread and widely unrecognized Throughout numerous articles, I’ve covered many aspects of the experience of…

Previously: Depersonalization in gender dysphoria: widespread and widely unrecognized Substance abuse is highly prevalent in the transgender population, and is…